{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:34:23Z","timestamp":1768343663856,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yunnan Provincial Education Department Scientific Research Fund Project","award":["2020J0187"],"award-info":[{"award-number":["2020J0187"]}]},{"name":"The Second Hospital Affiliated of Kunming Medical University Talent Echelon Cultivation Program","award":["RCTDHB-202303"],"award-info":[{"award-number":["RCTDHB-202303"]}]},{"name":"The Second Hospital Affiliated of Kunming Medical University Talent Echelon Cultivation Program","award":["RCTDHB-202309"],"award-info":[{"award-number":["RCTDHB-202309"]}]},{"name":"Yunnan Provincial Department of Science and Technology (Kunming Medical University Joint Special) Science and Technology Plan Project","award":["202301AY070001-273"],"award-info":[{"award-number":["202301AY070001-273"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02497-4","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T16:01:38Z","timestamp":1743177698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlation between thyroid hormone levels and the incidence and staging of bladder cancer"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9238-3143","authenticated-orcid":false,"given":"Jia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigang","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingyu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"2497_CR1","doi-asserted-by":"publisher","first-page":"1335149","DOI":"10.3389\/fendo.2024.1335149","volume":"15","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Mu Y, Jiang X, Zhao Y, Wang Q, Shen Z. Causal relationship between thyroid dysfunction and gastric cancer: a two-sample Mendelian randomization study. Front Endocrinol. 2024;15:1335149.","journal-title":"Front Endocrinol"},{"key":"2497_CR2","doi-asserted-by":"publisher","first-page":"e220155","DOI":"10.1530\/ERC-22-0155","volume":"30","author":"T-V-T Tran","year":"2023","unstructured":"Tran T-V-T, Kitahara CM, Leenhardt L, De Vathaire F, Boutron-Ruault M-C, Journy N. The effect of thyroid dysfunction on breast cancer risk: an updated meta-analysis. Endocr-relat Cancer. 2023;30:e220155.","journal-title":"Endocr-relat Cancer"},{"key":"2497_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1530\/ERC-20-0277","volume":"28","author":"HA Sterle","year":"2021","unstructured":"Sterle HA, Hildebrandt X, Valenzuela \u00c1lvarez M, Paulazo MA, Gutierrez LM, Klecha AJ, et al. Thyroid status regulates the tumor microenvironment delineating breast cancer fate. Endocr-relat Cancer. 2021;28:403\u201318.","journal-title":"Endocr-relat Cancer"},{"key":"2497_CR4","doi-asserted-by":"publisher","first-page":"e22661","DOI":"10.1016\/j.heliyon.2023.e22661","volume":"9","author":"W Liu","year":"2023","unstructured":"Liu W, Zhi F-H, Zheng S-Y, Yang H-S, Geng X-J, Luo H-H, et al. Hypothyroidism reduces the risk of lung cancer through oxidative stress response and the PI3K\/akt signaling pathway: an RNA-seq and mendelian randomization study. Heliyon. 2023;9:e22661.","journal-title":"Heliyon"},{"key":"2497_CR5","doi-asserted-by":"publisher","first-page":"108125","DOI":"10.1016\/j.toxicon.2024.108125","volume":"251","author":"S Lisieska-\u017bo\u0142nierczyk","year":"2024","unstructured":"Lisieska-\u017bo\u0142nierczyk S, Gaj\u0119cka M, Zielonka \u0141, D\u0105browski M, Gaj\u0119cki MT. Blood levels of zearalenone, thyroid-stimulating hormone, and thyroid hormones in patients with colorectal cancer. Toxicon. 2024;251:108125.","journal-title":"Toxicon"},{"key":"2497_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41419-024-06690-x","volume":"15","author":"MV Giolito","year":"2024","unstructured":"Giolito MV, Bodoirat S, Rosa T, Reslinger M, Guardia GDA, Mourtada J, et al. Impact of the thyroid hormone T3 and its nuclear receptor tr\u03b11 on colon cancer stem cell phenotypes and response to chemotherapies. Cell Death Dis. 2024;15:306.","journal-title":"Cell Death Dis"},{"key":"2497_CR7","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1002\/ijc.32988","volume":"147","author":"S Yuan","year":"2020","unstructured":"Yuan S, Kar S, Vithayathil M, Carter P, Mason AM, Burgess S, et al. Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: a two-sample Mendelian randomization study. Int J Cancer. 2020;147:1895\u2013903.","journal-title":"Int J Cancer"},{"key":"2497_CR8","doi-asserted-by":"publisher","first-page":"2196088","DOI":"10.1080\/07853890.2023.2196088","volume":"55","author":"Z Ma","year":"2023","unstructured":"Ma Z, Song P, Ji D, Zheng M, Qiu G, Liu Z, et al. Thyroid hormones as biomarkers of lung cancer: a retrospective study. Ann Med. 2023;55:2196088.","journal-title":"Ann Med"},{"key":"2497_CR9","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jhep.2019.12.018","volume":"72","author":"MA Kowalik","year":"2020","unstructured":"Kowalik MA, Puliga E, Cabras L, Sulas P, Petrelli A, Perra A, et al. Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming. J Hepatol. 2020;72:1159\u201369.","journal-title":"J Hepatol"},{"key":"2497_CR10","doi-asserted-by":"publisher","first-page":"599602","DOI":"10.3389\/fonc.2021.599602","volume":"11","author":"H Liu","year":"2021","unstructured":"Liu H, Gao Y, Vafaei S, Gu X, Zhong X. The prognostic value of plasma cell-free DNA concentration in the prostate cancer: a systematic review and meta-analysis. Front Oncol. 2021;11:599602.","journal-title":"Front Oncol"},{"key":"2497_CR11","doi-asserted-by":"publisher","first-page":"1239883","DOI":"10.3389\/fendo.2023.1239883","volume":"14","author":"H Dong","year":"2023","unstructured":"Dong H, Pan L, Shen Y, Xu Q, Hu J, Hu Z, et al. Thyroid dysfunction and risk of cutaneous malignant melanoma: a bidirectional two-sample Mendelian randomization study. Front Endocrinol. 2023;14:1239883.","journal-title":"Front Endocrinol"},{"key":"2497_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, et al. Bladder cancer. Nat Rev Dis Primers. 2023;9:58.","journal-title":"Nat Rev Dis Primers"},{"key":"2497_CR13","unstructured":"Campbell MF, Walsh PC, Wein AJ, Kolon TF, Partin AW, Dmochowski RR, et al. C.c.a. Campbell-walsh-wein Urol Twelfth Ed Rev."},{"key":"2497_CR14","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.3390\/jcm10194559","volume":"10","author":"S Sorrenti","year":"2021","unstructured":"Sorrenti S, Dolcetti V, Fresilli D, Del Gaudio G, Pacini P, Huang P, et al. The role of CEUS in the evaluation of thyroid cancer: from diagnosis to local staging. J Clin Med. 2021;10:4559.","journal-title":"J Clin Med"},{"key":"2497_CR15","doi-asserted-by":"publisher","first-page":"e004128","DOI":"10.1136\/bmjgh-2020-004128","volume":"6","author":"S Safiri","year":"2021","unstructured":"Safiri S, Kolahi A-A, Naghavi M. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. BMJ Glob Health. 2021;6:e004128.","journal-title":"BMJ Glob Health"},{"key":"2497_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41585-022-00591-4","volume":"19","author":"D Theodorescu","year":"2022","unstructured":"Theodorescu D, Li Z, Li X. Sex differences in bladder cancer: emerging data and call to action. Nat Rev Urol. 2022;19:447\u20139.","journal-title":"Nat Rev Urol"},{"key":"2497_CR17","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00259-020-05018-z","volume":"48","author":"P Petranovi\u0107 Ov\u010dari\u010dek","year":"2021","unstructured":"Petranovi\u0107 Ov\u010dari\u010dek P, Verburg FA, Hoffmann M, Iakovou I, Mihailovic J, Vrachimis A, et al. Higher thyroid hormone levels and cancer. Eur J Nucl Med Mol Imaging. 2021;48:808\u201321.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2497_CR18","doi-asserted-by":"publisher","first-page":"e13260","DOI":"10.1111\/acel.13260","volume":"19","author":"BR Gauthier","year":"2020","unstructured":"Gauthier BR, Sola-Garc\u00eda A, C\u00e1liz-Molina M\u00c1, Lorenzo PI, Cobo-Vuilleumier N, Capilla-Gonz\u00e1lez V, et al. Thyroid hormones in diabetes, cancer, and aging. Aging Cell. 2020;19:e13260.","journal-title":"Aging Cell"},{"key":"2497_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1158\/1078-0432.CCR-20-2647","volume":"27","author":"RS Wahdan-Alaswad","year":"2021","unstructured":"Wahdan-Alaswad RS, Edgerton SM, Salem H, Kim HM, Tan AC, Finlay-Schultz J, et al. Exogenous thyroid hormone is associated with shortened survival and upregulation of high-risk gene expression profiles in steroid receptor\u2013positive breast cancers. Clin Cancer Res. 2021;27:585\u201397.","journal-title":"Clin Cancer Res"},{"key":"2497_CR20","first-page":"227","volume":"58","author":"VS Ghalaut","year":"2012","unstructured":"Ghalaut VS, Yadav S, Ghalaut PS, Yadav A, Sachdeva A, Yadav R, et al. Association of insulin like growth factor-1 (IGF-1) and thyroid hormones in patients of acute leukemia. Clin Lab. 2012;58:227\u201331.","journal-title":"Clin Lab"},{"key":"2497_CR21","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1158\/1535-7163.MCT-22-0093","volume":"21","author":"F Cayrol","year":"2022","unstructured":"Cayrol F, Revuelta MV, Debernardi M, Paulazo A, Phillip JM, Zamponi N, et al. Inhibition of integrin \u03b1V\u03b23 signaling improves the antineoplastic effect of bexarotene in cutaneous T-cell lymphoma. Mol Cancer Ther. 2022;21:1485\u201396.","journal-title":"Mol Cancer Ther"},{"key":"2497_CR22","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3390\/jcm10081766","volume":"10","author":"U Abadi","year":"2021","unstructured":"Abadi U, Weisz A, Kidron D, Katzav A, Hercbergs A, Davis PJ, et al. \u0391v\u03b23 integrin expression and mitogenic effects by thyroid hormones in chronic lymphocytic leukemia. J Clin Med. 2021;10:1766.","journal-title":"J Clin Med"},{"key":"2497_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.5603\/EP.a2022.0020","volume":"73","author":"Z Lei","year":"2022","unstructured":"Lei Z, Zeng B, Wu L, Deng Q, Guo D. Free triiodothyronine and free thyroxine hormone levels in relation to breast cancer risk: a meta-analysis. Endokrynol Pol. 2022;73:309\u201315.","journal-title":"Endokrynol Pol"},{"key":"2497_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1530\/EJE-17-0197","volume":"177","author":"YX Chan","year":"2017","unstructured":"Chan YX, Knuiman MW, Divitini ML, Brown SJ, Walsh J, Yeap BB. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer. Eur J Endocrinol. 2017;177:297\u2013308.","journal-title":"Eur J Endocrinol"},{"key":"2497_CR25","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/S0022-5347(05)64161-4","volume":"168","author":"S Lehrer","year":"2002","unstructured":"Lehrer S, Diamond EJ, Stone NN, Droller MJ, Stock RG. Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia. J Urol. 2002;168:2431\u20133.","journal-title":"J Urol"},{"key":"2497_CR26","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.21873\/anticanres.14199","volume":"40","author":"PP Ov\u010dari\u010dek","year":"2020","unstructured":"Ov\u010dari\u010dek PP, Fr\u00f6be A, Verburg FA, Murgi\u0107 J, Butkovi\u0107 MB, Ov\u010dari\u010dek S, et al. Association of triiodothyronine levels with prostate cancer histopathological differentiation and tumor stage. Anticancer Res. 2020;40:2323\u20139.","journal-title":"Anticancer Res"},{"key":"2497_CR27","doi-asserted-by":"publisher","first-page":"e220228","DOI":"10.1530\/ETJ-22-0228","volume":"12","author":"S Torabinejad","year":"2023","unstructured":"Torabinejad S, Miro C, Barone B, Imbimbo C, Crocetto F, Dentice M. The androgen-thyroid hormone crosstalk in prostate cancer and the clinical implications. Eur Thyroid J. 2023;12:e220228.","journal-title":"Eur Thyroid J"},{"key":"2497_CR28","doi-asserted-by":"publisher","first-page":"9245","DOI":"10.3390\/ijms25179245","volume":"25","author":"B Hantusch","year":"2024","unstructured":"Hantusch B, Kenner L, Stanulovi\u0107 VS, Hoogenkamp M, Brown G. Targeting androgen, thyroid hormone, and vitamin a and D receptors to treat prostate cancer. Int J Mol Sci. 2024;25:9245.","journal-title":"Int J Mol Sci"},{"key":"2497_CR29","doi-asserted-by":"publisher","first-page":"215581","DOI":"10.1016\/j.canlet.2022.215581","volume":"532","author":"C Miro","year":"2022","unstructured":"Miro C, Di Giovanni A, Murolo M, Cicatiello AG, Nappi A, Sagliocchi S, et al. Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer. Cancer Lett. 2022;532:215581.","journal-title":"Cancer Lett"},{"key":"2497_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3892\/or.2022.8458","volume":"49","author":"O Rostkowska","year":"2022","unstructured":"Rostkowska O, Olejniczak-K\u0119der A, Spychalski P, Szary\u0144ska M, Kobiela J. Triiodothyronine lowers the potential of colorectal cancer stem cells in vitro. Oncol Rep. 2022;49:21.","journal-title":"Oncol Rep"},{"key":"2497_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12672-019-00374-1","volume":"11","author":"HC Puhr","year":"2020","unstructured":"Puhr HC, Wolf P, Berghoff AS, Schoppmann SF, Preusser M, Ilhan-Mutlu A. Elevated free thyroxine levels are associated with poorer overall survival in patients with gastroesophageal cancer: a retrospective single center analysis. Horm Cancer. 2020;11:42\u201351.","journal-title":"Horm Cancer"},{"key":"2497_CR32","doi-asserted-by":"publisher","first-page":"e193755","DOI":"10.1001\/jamanetworkopen.2019.3755","volume":"2","author":"A L\u2019Heureux","year":"2019","unstructured":"L\u2019Heureux A, Wieland DR, Weng C-H, Chen Y-H, Lin C-H, Lin T-H, et al. Association between thyroid disorders and colorectal cancer risk in adult patients in Taiwan. JAMA Netw Open. 2019;2:e193755.","journal-title":"JAMA Netw Open"},{"key":"2497_CR33","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1158\/1055-9965.EPI-08-0911","volume":"18","author":"AI Hellevik","year":"2009","unstructured":"Hellevik AI, \u00c5svold BO, Bj\u00f8ro T, Romundstad PR, Nilsen TIL, Vatten LJ. Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev. 2009;18:570\u20134.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2497_CR34","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1210\/jc.2016-2104","volume":"101","author":"SR Khan","year":"2016","unstructured":"Khan SR, Chaker L, Ruiter R, Aerts JGJV, Hofman A, Dehghan A, et al. Thyroid function and cancer risk: the Rotterdam study. J Clin Endocrinol Metab. 2016;101:5030\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"2497_CR35","doi-asserted-by":"publisher","first-page":"992608","DOI":"10.3389\/fnut.2023.992608","volume":"10","author":"Z Cheng","year":"2023","unstructured":"Cheng Z, Ye F, Liang Y, Xu C, Zhang Z, Ou Y, et al. Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a Mendelian randomization study. Front Nutr. 2023;10:992608.","journal-title":"Front Nutr"},{"key":"2497_CR36","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/hep.31296","volume":"72","author":"MJ Ritter","year":"2020","unstructured":"Ritter MJ, Amano I, Hollenberg AN. Thyroid hormone signaling and the liver. Hepatology. 2020;72:742\u201352.","journal-title":"Hepatology"},{"key":"2497_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cca.2022.01.006","volume":"527","author":"X Su","year":"2022","unstructured":"Su X, Peng H, Chen X, Wu X, Wang B. Hyperlipidemia and hypothyroidism. Clin Chim Acta. 2022;527:61\u201370.","journal-title":"Clin Chim Acta"},{"key":"2497_CR38","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s12282-020-01078-z","volume":"27","author":"X-F Pan","year":"2020","unstructured":"Pan X-F, Ma Y-J, Tang Y, Yu M, Wang H, Fan Y. Breast cancer populations may have an increased prevalence of thyroglobulin antibody and thyroid peroxidase antibody: a systematic review and meta-analysis. Breast Cancer. 2020;27:828\u201336.","journal-title":"Breast Cancer"},{"key":"2497_CR39","doi-asserted-by":"publisher","first-page":"336","DOI":"10.21037\/gs-20-878","volume":"10","author":"S Chen","year":"2021","unstructured":"Chen S, Wu F, Hai R, You Q, Xie L, Shu L, et al. Thyroid disease is associated with an increased risk of breast cancer: a systematic review and meta-analysis. Gland Surg. 2021;10:336\u201346.","journal-title":"Gland Surg"},{"key":"2497_CR40","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1101\/gad.314617.118","volume":"32","author":"H Gonzalez","year":"2018","unstructured":"Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018;32:1267\u201384.","journal-title":"Genes Dev"},{"key":"2497_CR41","doi-asserted-by":"publisher","first-page":"bqae115","DOI":"10.1210\/endocr\/bqae115","volume":"165","author":"X Zhu","year":"2024","unstructured":"Zhu X, Cheng S. Thyroid hormone receptors as tumor suppressors in cancer. Endocrinology. 2024;165:bqae115.","journal-title":"Endocrinology"},{"key":"2497_CR42","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1089\/thy.2019.0175","volume":"30","author":"I L\u00f3pez-Mateo","year":"2020","unstructured":"L\u00f3pez-Mateo I, Alonso-Merino E, Suarez-Cabrera C, Park JW, Cheng S, Alemany S, et al. Thyroid hormone receptor \u03b2 inhibits self-renewal capacity of breast cancer stem cells. Thyroid. 2020;30:116\u201332.","journal-title":"Thyroid"},{"key":"2497_CR43","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00018-022-04503-y","volume":"79","author":"MV Giolito","year":"2022","unstructured":"Giolito MV, Plateroti M. Thyroid hormone signaling in the intestinal stem cells and their niche. Cell Mol Life Sci. 2022;79:476.","journal-title":"Cell Mol Life Sci"},{"key":"2497_CR44","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.ccell.2024.07.008","volume":"42","author":"Y Yang","year":"2024","unstructured":"Yang Y, Vald\u00e9s-Rives SA, Liu Q, Gao T, Burudpakdee C, Li Y, et al. Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells. Cancer Cell. 2024;42:1434-1449.e5.","journal-title":"Cancer Cell"},{"key":"2497_CR45","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1002\/1878-0261.13298","volume":"16","author":"MV Giolito","year":"2022","unstructured":"Giolito MV, La Rosa T, Farhat D, Bodoirat S, Guardia GDA, Domon-Dell C, et al. Regulation of the THRA gene, encoding the thyroid hormone nuclear receptor TR\u03b11, in intestinal lesions. Mol Oncol. 2022;16:3975\u201393.","journal-title":"Mol Oncol"},{"key":"2497_CR46","doi-asserted-by":"publisher","first-page":"941552","DOI":"10.3389\/fonc.2022.941552","volume":"12","author":"M Serra","year":"2022","unstructured":"Serra M, Pal R, Puliga E, Sulas P, Cabras L, Cusano R, et al. mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma. Front Oncol. 2022;12:941552.","journal-title":"Front Oncol"},{"key":"2497_CR47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41417-018-0025-2","volume":"25","author":"M Panagal","year":"2018","unstructured":"Panagal M, P S, Gopinathe V, Sivakumare P, Sekar D, et al. MicroRNA21 and the various types of myeloid leukemia. Cancer Gene Ther. 2018;25:161\u20136.","journal-title":"Cancer Gene Ther"},{"key":"2497_CR48","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1158\/0008-5472.CAN-12-2218","volume":"73","author":"Y-H Huang","year":"2013","unstructured":"Huang Y-H, Lin Y-H, Chi H-C, Liao C-H, Liao C-J, Wu S-M, et al. Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma. Cancer Res. 2013;73:2505\u201317.","journal-title":"Cancer Res"},{"key":"2497_CR49","doi-asserted-by":"publisher","first-page":"188904","DOI":"10.1016\/j.bbcan.2023.188904","volume":"1878","author":"SC Selvakumar","year":"2023","unstructured":"Selvakumar SC, Preethi KA, Sekar D. MicroRNAs as important players in regulating cancer through PTEN\/PI3K\/AKT signalling pathways. Biochim Biophys Acta (BBA) - Rev Cancer. 2023;1878:188904.","journal-title":"Biochim Biophys Acta (BBA) - Rev Cancer"},{"key":"2497_CR50","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.canlet.2020.11.011","volume":"501","author":"D Moskovich","year":"2021","unstructured":"Moskovich D, Alfandari A, Finkelshtein Y, Weisz A, Katzav A, Kidron D, et al. DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer. Cancer Lett. 2021;501:224\u201333.","journal-title":"Cancer Lett"},{"key":"2497_CR51","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1152\/physrev.00038.2019","volume":"101","author":"PJ Davis","year":"2021","unstructured":"Davis PJ, Mousa SA, Lin H-Y. Nongenomic actions of thyroid hormone: the integrin component. Physiol Rev. 2021;101:319\u201352.","journal-title":"Physiol Rev"},{"key":"2497_CR52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13046-023-02757-3","volume":"42","author":"Y Li","year":"2023","unstructured":"Li Y, Kong Y, An M, Luo Y, Zheng H, Lin Y, et al. ZEB1-mediated biogenesis of circNIPBL sustains the metastasis of bladder cancer via wnt\/\u03b2-catenin pathway. J Exp Clin Cancer Res. 2023;42:191.","journal-title":"J Exp Clin Cancer Res"},{"key":"2497_CR53","doi-asserted-by":"publisher","first-page":"217339","DOI":"10.1016\/j.canlet.2024.217339","volume":"610","author":"M-S Jeong","year":"2025","unstructured":"Jeong M-S, Baek S-W, Yang G-E, Mun J-Y, Kim JA, Kim T-N, et al. Chemoresistance-motility signature of molecular evolution to chemotherapy in non-muscle-invasive bladder cancer and its clinical implications. Cancer Lett. 2025;610:217339.","journal-title":"Cancer Lett"},{"key":"2497_CR54","doi-asserted-by":"publisher","first-page":"101387","DOI":"10.1016\/j.beem.2020.101387","volume":"34","author":"A Antonelli","year":"2020","unstructured":"Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, Ruffilli I, et al. Graves\u2019 disease: epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab. 2020;34:101387.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2497_CR55","doi-asserted-by":"publisher","first-page":"1158013","DOI":"10.3389\/fendo.2023.1158013","volume":"14","author":"B Song","year":"2023","unstructured":"Song B, Lu C, Teng D, Shan Z, Teng W. Association between different metabolic phenotypes of obesity and thyroid disorders among Chinese adults: a nationwide cross-sectional study. Front Endocrinol. 2023;14:1158013.","journal-title":"Front Endocrinol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02497-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02497-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02497-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T03:48:00Z","timestamp":1743392880000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02497-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2497"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02497-4","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the study involving human participants conformed to the ethical standards of institutional and national research councils, and to the 1964 Declaration of Helsinki and its subsequent amendments or equivalent ethical standards. The study was approved by the Medical Ethics Committee of the Second Affiliated\u00a0Hospital of Kunming Medical University (Ethics Approval Number: PJ-2020\u2013156).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}